Company Filing History:
Years Active: 2019-2023
Title: The Innovations of Sergio Pablo Sardi
Introduction
Sergio Pablo Sardi is a notable inventor based in Newton, MA, who has made significant contributions to the field of biotechnology. With a total of three patents to his name, Sardi's work focuses on innovative solutions for treating genetic disorders, particularly Huntington's disease.
Latest Patents
Sardi's latest patents include groundbreaking RNA interference (RNAi) molecules. These RNAi molecules consist of a first strand containing a guide sequence and a second strand with a non-guide sequence that features a bulge opposite the seed region of the guide sequences. This innovative design aims to enhance the effectiveness of RNAi in treating Huntington's disease. Additionally, the patents cover expression cassettes, various vectors such as rAAV, recombinant adenoviral, recombinant lentiviral, and recombinant HSV vectors, as well as cells, viral particles, and pharmaceutical compositions that incorporate the RNAi. Methods and kits related to the application of this RNAi for therapeutic purposes are also included in his patents.
Career Highlights
Sardi is currently associated with Genzyme Corporation, a leading biotechnology company known for its focus on rare diseases and innovative therapies. His work at Genzyme has allowed him to contribute to the development of advanced treatments that address critical health challenges.
Collaborations
Sardi collaborates with talented professionals in his field, including coworkers Lisa M Stanek and Adam Palermo. Their combined expertise fosters an environment of innovation and progress in the research and development of new therapeutic solutions.
Conclusion
Sergio Pablo Sardi's contributions to biotechnology, particularly in the realm of RNAi for treating Huntington's disease, highlight his role as a significant inventor in the industry. His work continues to pave the way for advancements in medical treatments and therapies.